Populations Trials that could be included in an existing review Trials for new review topics to be considered Trials for new review topics to be considered
Menopause 65 (34%) 65 (34%) 115 (50%)
Gynaecological Surgery 61 (32%) 61 (32%) 53 (23%)
Polycystic Ovary Syndrome 12 (6%) 12 (6%) 26 (11%)
Painful Menstruation 16 (8%) 16 (8%) 10 (4%)
Endometriosis/Adenomyosis 13 (7%) 13 (7%) 11 (5%)
Heavy menstrual bleeding 6 (3%) 6 (3%) 5 (2%)
Fibroids 10 (5%) 10 (5%) 1 (0.4%)
Premenstrual Syndrome 4 (2%) 4 (2%) 8 (3%)
Disorders of Menstrual Cycling 3 (2%) 3 (2%) 1 (0.4%)
Chronic Pelvic Pain 2 (1%) 2 (1%) 0
Hyperandrogenism 0 0 0
Total 192 192 230